Optimization of dissolution test precision for a ketoprofen oral extended-release product

被引:32
作者
Furlanetto, S [1 ]
Maestrelli, F [1 ]
Orlandini, S [1 ]
Pinzauti, S [1 ]
Mura, P [1 ]
机构
[1] Univ Florence, Dept Pharmaceut Sci, I-50121 Florence, Italy
关键词
dissolution test; paddle apparatus; experimental design; ketoprofen; extended-release dosage form; validation;
D O I
10.1016/S0731-7085(03)00032-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
An example of application of experimental design methodologies to the set up of dissolution test conditions for a new ketoprofen oral extended-release dosage form is presented. The aim of the work was to find the best experimental conditions, using a USP apparatus 2 (paddle), for maximizing the method precision as degree of repeatability. The considered factors mainly influencing the dissolution test results were pH and volume of dissolution medium, and paddle stirring speed. Two distinct 4-run Plackett-Burman designs were carried out: one at gastric and the other at intestinal pH values. Each run was performed in triplicate in order to calculate the standard deviations of the drug dissolution efficiency at 60 and 120 min, selected as responses to be minimized. Optimum conditions to carry out the dissolution test were: 900 ml volume of dissolution medium and 70 rpm paddle stirring speed for both environments and pH 1 and 5.5, for the gastric and intestinal environment, respectively. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 17 条
[1]  
[Anonymous], DRUG INF J
[2]  
Box GEP., 1978, Statistics for experimenters
[3]   Biopharmaceutical characterization of oral immediate release drug products.: In vitro in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin [J].
Frick, A ;
Möller, H ;
Wirbitzki, E .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 46 (03) :305-311
[4]  
Guidance for industry, 1997, DISS TEST IMM REL SO
[5]  
HOENER B, 1990, MODERN PHARM, P143
[6]   Development of dissolution tests for oral extended-release products [J].
Jorgensen, ED ;
Bhagwat, D .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (03) :128-135
[7]   CONCEPT OF DISSOLUTION EFFICIENCY [J].
KHAN, KA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (01) :48-49
[8]  
Khan MZI, 1996, INT J PHARM, V140, P131
[9]  
Lewis G. A., 1999, PHARM EXPT DESIGN
[10]  
MATHIEU D, 2000, NEMRODW LPRAI SARL